Emmis Acquisition Corp. (EMIS)
EMIS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$10.28
0.00% on the day
Market cap
Blank-check company
Revenue
Blank-check company: no operating revenue
Net income
Blank-check company: no operating revenue
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | EMIS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0002075816 |
| SEC industry code | Blank Checks |
| Incorporated in | E9 |
Financials
Blank-check company: no operating revenue.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B4 | 2025-09-26 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-27 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-06 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-28 |
Source: SEC EDGAR submissions feed, 48 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OPK | OPKO Health Inc. | $1.32 | -4.35% | $985.2M |
| SVRA | Savara Inc. | $4.78 | -1.24% | $982.1M |
| MNKD | MannKind Corporation | $3.05 | -2.56% | $980.7M |
| LTGO | Latigo Biotherapeutics Inc. | $15.71 | -1.94% | $1.0B |
| JANX | Janux Therapeutics Inc. | $17.18 | -5.34% | $1.1B |
| AVLN | Avalyn Pharma Inc. | $23.74 | -4.27% | $1.1B |
| HROW | Harrow Inc. | $28.24 | -2.99% | $1.1B |
| AKTS | Aktis Oncology Inc. | $16.64 | -4.04% | $925.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier